BioAge Labs Statistics

Total Valuation

BioAge Labs has a market cap or net worth of $136.95 million. The enterprise value is -$208.70 million.

Market Cap	136.95M
Enterprise Value	-208.70M

Important Dates

The next estimated earnings date is Thursday, May 15, 2025, before market open.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

BioAge Labs has 35.85 million shares outstanding. The number of shares has increased by 541.23% in one year.

Current Share Class	35.85M
Shares Outstanding	35.85M
Shares Change (YoY)	+541.23%
Shares Change (QoQ)	+930.56%
Owned by Insiders (%)	3.64%
Owned by Institutions (%)	44.11%
Float	23.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.42
P/TBV Ratio	0.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.86, with a Debt / Equity ratio of 0.03.

Current Ratio	12.86
Quick Ratio	12.76
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-33.04

Financial Efficiency

Return on equity (ROE) is -50.35% and return on invested capital (ROIC) is -28.38%.

Return on Equity (ROE)	-50.35%
Return on Assets (ROA)	-25.44%
Return on Invested Capital (ROIC)	-28.38%
Return on Capital Employed (ROCE)	-23.66%
Revenue Per Employee	n/a
Profits Per Employee	-$1.11M
Employee Count	64
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	4.55
200-Day Moving Average	n/a
Relative Strength Index (RSI)	34.38
Average Volume (20 Days)	158,270

Short Selling Information

The latest short interest is 1.75 million, so 4.89% of the outstanding shares have been sold short.

Short Interest	1.75M
Short Previous Month	1.85M
Short % of Shares Out	4.89%
Short % of Float	7.36%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-78.19M
Pretax Income	-62.16M
Net Income	-71.11M
EBITDA	-78.03M
EBIT	-78.19M
Earnings Per Share (EPS)	-$6.63

Full Income Statement

Balance Sheet

The company has $354.35 million in cash and $8.70 million in debt, giving a net cash position of $345.65 million or $9.64 per share.

Cash & Cash Equivalents	354.35M
Total Debt	8.70M
Net Cash	345.65M
Net Cash Per Share	$9.64
Equity (Book Value)	323.13M
Book Value Per Share	9.01
Working Capital	329.33M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$51.52 million and capital expenditures -$366,000, giving a free cash flow of -$51.89 million.

Operating Cash Flow	-51.52M
Capital Expenditures	-366,000
Free Cash Flow	-51.89M
FCF Per Share	-$1.45

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAge Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-541.23%
Shareholder Yield	n/a
Earnings Yield	-51.92%
FCF Yield	-37.89%

Analyst Forecast

The average price target for BioAge Labs is $5.67, which is 48.43% higher than the current price. The consensus rating is "Hold".

Price Target	$5.67
Price Target Difference	48.43%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3